Daily News header

UC Davis Spearheads 'What's Good for The Body is Good for The Brain' Symposium

"What's Good for The Body is Good for The Brain" The Topic of Alzheimer's Disease Center Symposium

The UC Davis Alzheimer's Disease Center will hold its first annual research symposium and poster session titled "What is Good for the Body is Good for the Brain," on Thursday, Nov. 1, from 4 p.m. to 6:30 p.m. in lecture hall 2222 in the Education Building, 4610 X St., Sacramento, Calif.

The event will feature welcomes from Chong Porter, associate vice chancellor of Health Sciences Development and Alumni Relations, and Charles DeCarli, director of the Alzheimer's Disease Center. It is being held in recognition of National Alzheimer's Disease Month in November.

Two researchers, Heike Wulff, associate professor in the Department of Pharmacology, and Owen Carmichael, assistant professor in the Department of Neurology, will give brief presentations on their research. Wulff will discuss "Microglial Potassium Channels as Potential Novel Targets for Alzheimer's Disease" at 4:40 p.m., followed by a discussion of "Development of MRI-Based Measures of Local Hippocampus Atrophy" by Carmichael at 4:50 p.m.

DeCarli will then moderate a panel discussion, "What's Good for the Body is Good for the Brain," at 5 p.m. Panelists will include Lars Berglund, director of the UC Davis Clinical and Translational Science Center; Jan Nolta, director of the UC Davis Center for Regenerative Cures; Bruce Reed, associate director of the Alzheimer's Disease Center; and John Rutledge, vice chair of research in the Department of Internal Medicine. The poster session will follow at 5:30 p.m.

The event is sponsored by the Alzheimer's Disease Center, Sunrise Senior Living, the Alzheimer's Aid Center, CiminoCare and the Asian Community Center's Bridge to Healthy Families Project. For further information, please contact Jayne La Grande, Alzheimer's Disease Center, at 916-734-5728.

The UC Davis Alzheimer's Disease Center is one of only 29 research centers designated by the National Institutes of Health's National Institute on Aging. The center's goal is to translate research advances into improved diagnosis and treatment for patients while focusing on the long-term goal of finding a way to prevent or cure Alzheimer's disease. Also funded by the state of California, the center allows researchers to study the effects of the disease on a uniquely diverse population. For more information, visit alzheimer.ucdavis.edu.

If you leave a comment and it does not display within 10 seconds, please refresh the page

Related Health News News

Fish Oil Market is Expected to Reach USD 1.7 Billion Globally in 2018: Transparency Market Research
RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
Novo A/S, a holding company of the Novo Group has acquired anti-infective developers and manufacturers Xellia Pharmaceuticals for US$ 700 million
InVivo Therapeutics Holdings Corp. , a developer of groundbreaking technologies for the treatment of spinal cord injuries and other neurotrauma conditions, today announced that an interview with InVivo Chief Executive Officer Frank Reynolds is ...
Kineta, Seattle biotech, announces large investment from Hydra LLC, a group of former Glencore oil and gas traders
RF IDeas announced that the pcProx and pcProx Plus line of card readers now offer IP67 compliance. This new certification rating will deliver greater flexibility to customers.

 

NewsBlaze Writers Of The Month



Popular Stories This Month

newsletter logo

NewsBlaze
Copyright © 2004-2013 NewsBlaze Pty. Ltd.
Use of this website is subject to our Terms of Service and Privacy Policy  | DMCA Notice               Press Room   |    Visit NewsBlaze Mobile Site